Dihydromyricetin (DHM) exerted neuroprotective effects in APP/PS1 mice, which significantly ameliorated memory and cognitive deficits, decreased activated microglia, reduced expression and activation of NLRP3 inflammasomes in APP/PS1 mice (Feng et al., 2018). The gene discussed is PSEN1; the disease is Cognitive impairment.